Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Pharma’s Path to Adopting AI and Other Emerging Technologies

Posted on February 7th, 2018 by in Pharma R&D

Right now in the pharmaceutical space, emerging technologies are dominating the conversation. As the cost of drug development soars, and the potential for success seems more and more elusive, the industry is pinning its hopes on promising technological breakthroughs. Continue reading “Pharma’s Path to Adopting AI and Other Emerging Technologies” »

Solving Global Research Challenges with Artificial Intelligence

Posted on January 8th, 2018 by in Pharma R&D

board-1364652_1280

In the 21st century, we are facing a number of enormous global challenges. Simply producing enough food and clean water to nourish the planet’s growing population is one of the biggest difficulties. Meanwhile, we must also deal with the ravages of climate change and take on medical problems like antibiotic resistance. Continue reading “Solving Global Research Challenges with Artificial Intelligence” »

As The Hive Evolves, More Companies Prepare to Join the Program

Posted on December 11th, 2017 by in Pharma R&D

This year, four companies working in early-stage drug development were able to power their efforts with an array of Elsevier tools by participating in The Hive. Now, more promising pharma and biotech start-ups are in the process of entering into The Hive Continue reading “As The Hive Evolves, More Companies Prepare to Join the Program” »

As Drug Development Costs Skyrocket, AI Offers Some Hope

Posted on November 20th, 2017 by in Pharma R&D

Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics. Continue reading “As Drug Development Costs Skyrocket, AI Offers Some Hope” »

  1. 1
  2. 2